Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute Harvard Medical School: 2014 Kenneth W. Kinzler, PhD Johns Hopkins Kimmel Cancer Center: 2014 Richard Kolodner, PhD Ludwig Institute for Cancer Research: 2014 Ronald Levy, MD Stanford University School of Medicine: 2014 Frederick Pei Li, MD Deceased (1940-2015) 2014 David M. Livingston, MD Dana–Farber Cancer ...
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr. Livingston joined the Harvard faculty in 1973. [3]
Mary-Ellen Taplin (born 1960), is a research oncologist at Dana Farber Cancer Institute and Brigham and Women's Hospital in Harvard's Longwood Medical and Academic Area. Taplin is Institute Physician and Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana Farber Cancer Institute and at the Brigham and Women's ...
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School.D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility.
In 2000, Wu joined the Dana-Farber faculty and began her independent research program in 2005. [1]In 2011, Wu was the recipient of a Stand Up To Cancer Innovative Research Grant for her project "Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia."
He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital. [1] [2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic ...